Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Citycon’s Financial Reporting Schedule and AGM in 2020

CITYCON OYJ   Stock Exchange Release   24 October 2019 at 09:05 hrsCitycon Oyj’s schedule of the financial reporting in 2020 is the following: Year 2019 full-year Financial Thursday 6 February 2020 at about 9:00 a.m.Report, Financial Statements andthe Report by the Board ofDirectorsYear 2020 three-month Interim Thursday 23 April 2020 at about 9:00 a.m.ReportYear 2020 six-month Half-Yearly Friday 10 July 2020 at about 9:00 a.m.ReportYear 2020 nine-month Interim Thursday 15 October 2020 at about 9:00 a.m.Report Citycon Oyj’s Annual General Meeting (AGM)

InDex Pharmaceuticals presents today at Redeye Investor After Work

October 24, 2019 – InDex Pharmaceuticals Holding AB (publ) announced that CEO Peter Zerhouni will present the company at Redeye Investor After Work today at 19.30 CET at Scandic Rubinen, Kungsportsavenyen 24, in Gothenburg. The presentation will be livestreamed and can be followed at https://www.redeye.se/live/inv-aw-gbg-24-10.The presentation will also be available afterwards on the company’s page in Redeye Universe (www.redeye.se/company/index-pharmaceuticals), as well as on the company’s website (www.indexpharma.com).   For more information:Peter Zerhouni, CEOPhone: +46 8 508

Asarina Pharma has completed a directed share issue of approximately SEK 48 million

Asarina Pharma AB (publ) (Nasdaq First North Growth Market: ASAP) (”Asarina Pharma” or the “Company”) today announces that the Company has successfully completed a directed share issue of 2,159,148 shares, corresponding to approximately SEK 48 million. In addition, existing shareholders have due to high demand sold 764,329 existing shares, corresponding to approximately SEK 17 million, in connection with the issue. The issue was subscribed for by a few institutional investors, including the Fourth AP Fund, Swedbank Robur, Östersjöstiftelsen and Handelsbanken.The board of directors of

Quarterly Report July - September 2019 Everysport Media Group AB (publ)

Results continue to improveThis is a translated version of the Swedish original, in case of deviations is the Swedish version considered to be the one to apply. This information is such information that Everysport Media Group AB (publ.) Is required to publish in accordance with the EU Market Abuse Regulation.The information was provided, through the agency of the above contact person, for publication on October 24th, 2019. Summary of the third quarter 2019 • Net sales: 21,0 mkr (20,6 mkr) • EBITDA: 2,7 mkr (2,3 mkr) • Profit after tax -0,7 mkr (-1.0 mkr) • Earnings per

Interim Report for 3rd Quarter 2019

Key Facts for the 3rd Quarter 2019 (1st July 2019 – 30th September 2019) All time high in Revenues and Profits All figures are compared to the same quarter last year if not explicitly stated otherwise · Revenues increased by 102.20% to €7,636,436 (€3,776,644). · EBIT increased by 130.28% to €2,420,802 (€1,051,254). · EBIT margin of 31.70% (27.84%). · Customer deposits increase of 188.82% to €20,162,937 (€6,981,253).  · 47,826 new registered customers (26,550), increase of 80.14%. · 21,721 new depositing customers (8,189), increase of 165.25%. · Earnings per share

Notice of annual shareholders’ meeting of AcadeMedia AB (publ)

The shareholders of AcadeMedia AB (publ) are summoned to the annual shareholders’ meeting on Tuesday 26 November 2019 at 2 p.m. at Näringslivets Hus, Storgatan 19, Stockholm. Registration starts at 1 p.m.   Right to attend the shareholders’ meeting Shareholders who wish to attend the annual shareholders’ meeting must · be registered in the share register maintained by Euroclear Sweden AB on Wednesday 20 November 2019, and must also · notify the company of their intention to attend the meeting, no later than Wednesday 20 November 2019. The notification must be made in

Viking Glory will be one of the most climate-smart passenger ships in the world

Thanks to its advanced solutions and technical innovations, M/S Viking Glory will be one of the most climate-smart passenger ships in the world. It is estimated that the ship will consume up to 10% less fuel than M/S Viking Grace, which is smaller and was hailed as the world’s most eco-friendly ship of its time.Viking Glory will launch into service in 2021 as the first ship in the world to be equipped with Wärtsilä 31DF dual fuel engines, which utilise the latest technology and run on completely sulphur-free liquefied natural gas (LNG). As with Viking Grace, Viking Glory will also have the

Revenio Group Corporation: Increased number of shares entered into trade register

Revenio Group Corporation, Stock exchange release, October 24, 2019 at 9.00Revenio Group Corporation: Increased number of shares entered into trade register Revenio Group Corporation, Stock Exchange Release, October 24, 2019 at 9:00 INCREASED NUMBER OF SHARES ENTERED INTO TRADE REGISTER Total of 44,367 new share subscriptions based on the company's 2015B stock options and total of 12,900 new share subscriptions based on the company’s 2015C stock options approved by the Board of Directors of Revenio Group Corporation on October 7, 2019, have been entered into the trade register

DDM Holding AG and DDM Debt AB to report third quarter and YTD January – September 2019

DDM Holding AG (First North Growth Market: DDM) and its subsidiary DDM Debt AB (Nasdaq Stockholm: DDM2) will publish their Q3 and YTD January – September 2019 interim reports on Thursday 7 November 2019 at 08:00 CET. Mr. Henrik Wennerholm, CEO, and Mr. Fredrik Olsson, CFO, will host a conference call the same day, beginning at 10:00 CET, to present and comment on the DDM Group’sfinancial results. The conference will be held in English and can be followed live on www.ddm-group.ch  or by telephone with dial-in numbers: Sweden: +46 8 505

News conference on Kojamo’s Interim Report for January–September 2019 on 6 November 2019

Kojamo plc Press Release, 24 October 2019 at 9:00 a.m. EESTNews conference on Kojamo’s Interim Report for January–September 2019 on 6 November 2019 Kojamo plc’s Interim Report for January–September 2019 will be published on Wednesday, 6 November 2019 at approximately 8:00 a.m. EEST. News conference and webcast Kojamo will hold a news conference for institutional investors, analysts and media on 6 November 2019 at 10:00 a.m. at its headquarters at Mannerheimintie 168A, Helsinki, Finland. The event will be hosted by Kojamo’s CEO Jani Nieminen and CFO Erik Hjelt, and it will be held

AQ Group AB (publ), interim report January - September, 2019

Third quarter, July-September 2019 in brief · 100 consecutive quarters with profit · More than SEK 5 billion in turnover the last 12 months · Very strong profit improvement due to comparison with large extraordinary costs · Strong cash flow and continued good growth driven by acquisitions · Net sales increased by 9.6% to SEK 1 247 million (1 137) · Operating profit (EBIT) increased to SEK 87 million (22) · Profit after financial items (EBT) increased to SEK 82 million (21) · Profit margin before tax (EBT %) was 6.6 % (1.9) · Cash flow from operating activities

Munters third quarter 2019

Stable demand, strong organic net sales growth and improved profitabilityIn September 2019, the closure of the Data Center Factory in Dison, Belgium, was decided. This business is reported as discontinued operations in this interim report and the income statement for 2019 and 2018 has been restated to reflect this change. The CEO comments and business comments in this report focus on the continuing operations, unless otherwise stated. CEO commentsMarket conditions stableOverall, markets in the third quarter were characterized by stable demand. Demand remained strong in some areas of

Interim report January – September 2019

GOOD SALES AND HIGH PRODUCTION VOLUMERevenue decreased to SEK 11,381m (12,011) and the revenue excluding JM Construction Business area Construction (under closure) amounted to SEK 11,159m (11,343) Operating profit was SEK 1,449m (1,443) 1). The operating margin increased to 12.7 percent (12.0). Operating profit excluding JM Construction Business area Construction was SEK 1,656m (1,519) and the operating margin to 14.8 percent (13.4) Gains from the sale of two completed rental unit properties of SEK 170m are included in the operating profit. Profit before tax amounted to SEK 1,387m (

Alligator Bioscience AB Interim report January-September 2019

"We are now regaining the exclusive, global rights to develop and commercialize ADC-1013 and at the same time receive enough ADC-1013 substance to, with or without a new partner, bring ADC-1013 into Phase II clinical trials next year. In total, we now have three projects in clinical development, and soon another one where the first patient in Phase I will be dosed”, commented CEO Per Norlén. Significant events July-September• Alligator regains the global rights for the CD40 antibody ADC-1013 (mitazalimab) from Janssen.• Alligator continued its work on the clinical development plan

Attendo’s report for the third quarter 2019: Stable performance despite challenges

Attendo shows good growth but continued pressure on margins in the third quarter of 2019. The quarter was marked by a more stable cost development and increased new sales. In Finland, a number of measures have been taken to strengthen the operations long-term, increase satisfaction and restore profitability. During the quarter, Attendo has agreed on a new long-term loan financing with more flexible terms.President and CEO Martin Tivéus comments on the report “Attendo delivers good growth and stable results, given challenging conditions. We have initiated the turn-around programme in

Interim Report January–September 2019

Strong order intake and launches for the future “Order intake increased by 52 percent, with strong contributions from both Assembly Solutions and Pattern Generators. The third quarter signaled the launch of Evo, Mycronic’s new control platform, which will form a cornerstone of our mask writers and strengthen our customer offering. After the end of the quarter, SLX was launched, which is Mycronic’s new mask writer for the semiconductor market,” says Anders Lindqvist, President and CEO. Third quarter · Order intake increased 52 percent to SEK 1,238 (813) million · Net sales

Higher net sales and stable operating profit

Peab´s Quarterly report January – September 2019July – September 2019 · Net sales SEK 13,001 million (12,445) · Operating profit SEK 727 million (743). Charged with SEK 40 millionreferring to acquisition costs from the deal with YIT · Operating margin 5.6 percent (6.0) · Pre-tax profit SEK 706 million (750) · Earnings per share SEK 2.00 (2.05) · Orders received SEK 9,349 million (11,473) · Cash flow before financing SEK -341 million (-876) January – September 2019 · Net sales SEK 38,696 million (37,388) · Operating profit SEK 1,813 million (1,710) ·

SEMCON INTERIM REPORT JANUARY-SEPTEMBER 2019

Significantly improved earningsThird quarter · The operating income amounted to SEK 410 million (405) and the organic growth was 1.6%. · The operating profit amounted to SEK 32 million (18), yielding an operating margin of 7.8% (4.4) · The profit after tax amounted to SEK 24 million (14) · Earnings per share (EPS) after dilution amounted to SEK 1.34 (0.75) January-September · The operating income amounted to SEK 1,369 million (1,353) and the organic growth was 0.6%. · The operating profit amounted to SEK 93 million (79), yielding an operating margin of 6.8% (5.8)

REPORT ON THE THIRD QUARTER 2019

· Net sales for the quarter were SEK 4,605 m (4,501); an increase of 2%, of which -6% was organic growth. · Operating profit before depreciation and amortization (EBITDA) for the quarter was SEK 792 m (835), representing a margin of 17.2% (18.6%). · Operating profit (EBIT) for the quarter was SEK 583 m (702), representing a margin of 12.7% (15.6%). · Items affecting comparability in the quarter were SEK -37 m (-) and related to initial restructuring measures executed in Q3. · Operating profit (EBIT) before items affecting comparability for the quarter was SEK 619 m (702),

Clavister Appoints Håkan Rippe as new CFO

Former CFO of Enea joins Clavister, bringing solid financial stewardship and experience.Örnsköldsvik, Sweden, October 24th, 2019. Clavister, a leader in high-performance cybersecurity solutions, welcomes Håkan Rippe as new CFO to the company, effective 1st of November. Rippe is a proven financial leader with a depth of knowledge and proven experience in the tech and software sector.  At Enea, he was instrumental in helping the company achieve seven consecutive years of EBITDA growth as well as executing billion sized debt and equity financing. Rippe was also project lead for Enea’s

DDM Holding AG and DDM Debt AB to report third quarter and YTD January – September 2019

DDM Holding AG (First North Growth Market: DDM) and its subsidiary DDM Debt AB (Nasdaq Stockholm: DDM2) will publish their Q3 and YTD January – September 2019 interim reports on Thursday 7 November 2019 at 08:00 CET. Mr. Henrik Wennerholm, CEO, and Mr. Fredrik Olsson, CFO, will host a conference call the same day, beginning at 10:00 CET, to present and comment on the DDM Group’s financial results. The conference will be held in English and can be followed live on www.ddm-group.ch  or by telephone with dial-in numbers: Sweden: +46 8 505 583

Interim report January – September 2019

Continued positive growth in Accessibility. Patient Handling Institutional US and Brexit uncertainties impact revenues. The Board has initiated a strategic review aimed to uncover underlying value Third quarter 2019 · Revenue amounted to MEUR 65.6 (65.2) · Organic growth was 0.2% (0.4) · The gross margin was 41.2% (44.0) · Adjusted EBITA amounted to MEUR 4.7 (5.9), corresponding to a margin of 7.2% (9.1) · EBIT amounted to MEUR 3.2 (4.5), corresponding to a margin of 4.9% (6.9) · Net profit (including discontinued operations) amounted to MEUR 3.9 (3.5) · Earnings

AstraZeneca year-to-date and Q3 2019 results

AstraZeneca PLC 24 October 2019 07:00 BST Year-to-date and Q3 2019 results Patients to benefit from further pipeline progress; sales-growth momentum driving operating leverage Year-to-date Product Sales growth of 13% (17% at CER1) to $17,315m included third-quarter Product Sales of $6,132m (+16%, +18% at CER). The third quarter again saw all three therapy areas and every sales region produce encouraging performances, including: · The continued performance of new medicines2, with sales growth in the quarter of 62% (+64% at CER) to $2,707m, including new-medicine growth in

Citycon Oyj’s Interim Report for 1 January – 30 September 2019: Another solid quarter

Citycon Oyj   Interim Report   24 October 2019 at 09:00 hrs- Solid overall performance in January-September- Total tenant sales grew by 4%; like-for-like sales by 1%- Total footfall increased by 5%; like-for-like footfall by 1%- Net rental income continued to grow, including like-for-like net rental income growth- Continued positive leasing spread driven by Sweden- Outlook narrowed after solid January-September performance and completed disposals JULY—SEPTEMBER 2019 - Net rental income was EUR 54.2 million (Q3/2018: 53.6). Development project in Mölndal coming online

There are no items matching the current filter
There are no more items matching the current filter
Back to top